SEC Form 4 · accession 0001209191-15-053402
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fuad El-Hibri
Officer — Chairman · Director · 10% Owner
Period of report
Jun 11, 2015
Accepted (ET)
Jun 15, 2015 · 5:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 11, 2015 | S | 30,000 | $32.2641 | D | 1,965,632 | D | |
| Common StockF3 | Jun 12, 2015 | S | 15,068 | $32.0301 | D | 1,950,564 | D | |
| Common Stock | Jun 15, 2015 | S | 368 | $32.00 | D | 1,950,196 | D | |
| Common StockF4 | holding | — | — | — | 2,350,331 | I | By Intervac, L.L.C. | |
| Common StockF5 | holding | — | — | — | 1,524,155 | I | By Biovac, L.L.C. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1All sales listed on this Form 4 were made by the Reporting Person pursuant to a plan, adopted on May 11, 2015, that is intended to comply with Rule 10b5-1(c) under the Exchange Act.
- F2The shares of Common Stock were sold at prices ranging from $31.99 to $32.62. Upon request, the Reporting Person will provide to the SEC staff, the Issuer and any security holder of the Issuer the full information regarding the separate sales prices.
- F3The shares of Common Stock were sold at prices ranging from $32.01 to $32.18. Upon request, the Reporting Person will provide to the SEC staff, the Issuer and any security holder of the Issuer the full information regarding the separate sales prices.
- F4Mr. El-Hibri's holdings through Intervac, L.L.C. include 1,638,403 shares of Common Stock held by Mr. El-Hibri and his wife, as tenants by the entirety, through their 37.7% equity interest in Intervac, L.L.C.; 127,721 shares held by Mr. El-Hibri's wife; and 584,207 shares held by trusts indirectly controlled by Mr. El-Hibri or his wife. Mr. El-Hibri disclaims beneficial ownership, for purposes of Section 16 of the Exchange Act or otherwise, of those shares held solely by his wife and those shares held by the trusts.
- F5Mr. El-Hibri holds individually and with his wife, as tenants by the entirety, an aggregate 89.2% equity interest in Biovac, L.L.C. Biovac, L.L.C. is the direct owner of 1,524,155 shares of Common Stock. Mr. El-Hibri disclaims beneficial ownership of the shares of Common Stock directly owned by Biovac, L.L.C. for purposes of Section 16, except to the extent of his pecuniary interest in 1,359,546 shares.